Skip to main content
. 2021 Oct 25;13(11):1785. doi: 10.3390/pharmaceutics13111785

Table 3.

Nanoparticles for immunomodulation.

Nanoparticle Mechanism of Action Tumor Type
MIL88B/RSL3 M1 polarization of TAMs Mouse mammary 4T1 tumor
ZVI-NP M1 polarization of TAMs
CD8+T cell increase
Regulatory T cells reduction
Human A549 lung carcinoma
Human H460 lung carcinoma
Human HT1299 lung carcinoma
Mouse LLC lung carcinoma
Pa-M/Ti-NC M1 polarization of TAMs
Generation of an immunogenic microenvironment that favors ferroptosis
Mouse mammary 4T1 tumor